Accessibility: Skip TopNav
AXIM Photo 1.jpg
AXIM Biotech presents AX-1602: the world’s first patent-pending formulation containing cannabigerol (CBG) and other cannabinoids as a treatment for psoriasis and atopic eczema.
Format
JPEG
Source
AXIM BIOTECHNOLOGIES, INC
Downloads
Original
Large
Medium
Small